Filtrer vos résultats
- 3
- 2
- 1
- 3
- 1
- 2
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trialthe 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.505P, ⟨10.1093/annonc/mdx393.031⟩
Communication dans un congrès
hal-01632415v1
|
||
|
609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutationthe 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. ⟨10.1093/annonc/mdx393.134⟩
Communication dans un congrès
hal-01632463v1
|
||
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialEuropean Journal of Cancer, 2018, 104, pp.108-116. ⟨10.1016/j.ejca.2018.09.006⟩
Article dans une revue
hal-01960176v1
|